COSOPT: Los dos componentes del glaucoma - Referencias

  1. Costa VP, Harris A, Stefánsson E, y cols. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Ret Eye Res. 2003;22:769-805.

  2. Flammer J, Orgül S, Costa VP, y cols. The impact of ocular blood flow in glaucoma. Prog Ret Eye Res. 2002;21:359-393.

  3. Lesk MR, Lachaine J. Medical therapy of glaucoma: Focus on newer agents. Ophthal Pract. 2003;21(2):1-7.

  4. Logan JF, Rankin SJ, Jackson AJ. Retinal blood flow measurements and neuroretinal rim damage in glaucoma. Br J Ophthalmol. 2004;88:1049-1054.
 
PrintImprimir esta página
05-11-CST-2009-LAMT-1322113-W

† Marca registrada de Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Whitehouse Station, N.J., E.U.A.

Derechos reservados © 2003 Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Whitehouse Station, N.J., E.U.A

Privacy Policy Terms of Use Coyright © 1995-2007 Merck & CO